CONTROVERSIES IN ASSISTED REPRODUCTION. (HARDBACK)

Foreword
List of contributors
1 The use of ovarian markers
Neena Malhotra and Siladitya Bhattacharya
2 The use of molecular markers of endometrial receptivity
Alejandro Rincon, David Bolumar, Diana Valbuena, and Carlos Simon
3 The use of GnRHa for the Triggering of Final Oocyte Maturation during Ovarian Stimulation Cycles
Dalia Khalife, Jad Farid Assaf, and Johnny Awwad
4 The use of time-lapse embryo imaging in ART practice
Fadi Choucair, Chantal Farra, and Johnny Awwad
5 The use of cryopreservation for all embryos
Samuel Santos-Ribeiro, Shari Mackens, Biljana Popovic-Todorovic, Annalisa Racca, Christophe Blockeel, and Panagiotis Drakopoulos
6 The use of Pre-implantation Genetic Screening
Yusuf Beebeejaun and Sesh Sunkara
7 The use of Single Embryo Transfer
Abha Maheshwari
8 The use of luteal-phase support
Laura Melado, Barbara Lawrenz, and Human Fatemi
9 Measuring Safety and Efficiency in IVF
Nicole C. Michel, Natalie Shammas, and Shima Elbakhit Albasha
10 To Flush Follicles during Egg Collection or not?
Hans-Peter Steiner
11 The use of blastocyst culture
Mohamed A. Aboulghar and Mona M. Aboulghar
12 The use of mitochondrial donation
Andy Greenfield
13 Controversies in recurrent implantation failure: from theory to practice
Efstratios Kolibianakis, Pavlidi Olga, and Christos A. Venetis
14 Fibroids - to remove or not?
Abdel-Maguid Ramzy
15 Limitations of Endometrioma Surgery in IVF: Possibilities of Early Disease Control
Vasilios Tanos and Elsie Sowah
Index

Assisted Reproduction is a specialty undergoing rapid change as new technologies are introduced and new research challenges previous treatment options. This text examines a selection of controversial topics for both laboratory and clinical practice and tries to place them in perspective, so readers can understand how and why the current state of the question has come about and how future contributions to the debate should be measured. All physicians involved with the technologies concerned will learn from the expert contributions assembled here.

Authors
• Botros Rizk, MD, MA, FRCOG, FRCS, HCLD, FACOG, FACS
Medical Director, California Elite Fertility, Pasadena, California, USA and Shanghai, China; President, Middle East Fertility Society; and formerly Professor and Head, Reproductive Endocrinology & Infertility, Department of Obstetrics & Gynecology, University of South Alabama, Mobile, Alabama, USA
• Yakoub Khalaf, MB BCh, MSc, MD, FRCOG, MFFP
Professor of Reproductive Medicine and Surgery at Guy's and St Thomas' Hospital and King's College London, and Head of Fertility Service and Director of the Assisted Conception Unit and Centre for Pre-Implantation Genetic Diagnosis at Guy's and St Thomas’ Hospital, London, UK